News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,034 Results
Type
Article (13829)
Company Profile (101)
Press Release (252104)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88212)
Career Advice (465)
Deals (15375)
Drug Delivery (68)
Drug Development (36670)
Employer Resources (49)
FDA (6297)
Job Trends (6208)
News (150482)
Policy (14064)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (3)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 BioForest Digital (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Standard (1)
Academia (445)
Accelerated approval (2)
Adcomms (6)
Allergies (32)
Alliances (23271)
ALS (36)
Alzheimer's disease (396)
Antibody-drug conjugate (ADC) (38)
Approvals (6333)
Artificial intelligence (106)
Autoimmune disease (9)
Automation (4)
Bankruptcy (150)
Best Places to Work (4378)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (20)
Brain cancer (16)
Breast cancer (78)
Cancer (601)
Cardiovascular disease (70)
Career advice (407)
Career pathing (11)
CAR-T (22)
Cell therapy (87)
Cervical cancer (4)
Clinical research (30959)
Collaboration (334)
Compensation (152)
Complete response letters (17)
COVID-19 (760)
CRISPR (20)
C-suite (121)
Cystic fibrosis (37)
Data (625)
Denatured (15)
Depression (9)
Diabetes (78)
Diagnostics (1327)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (60)
Drug pricing (64)
Drug shortages (12)
Duchenne muscular dystrophy (36)
Earnings (32157)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (37525)
Executive appointments (383)
FDA (6714)
Featured Employer (20)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (209)
Gene editing (38)
Generative AI (9)
Gene therapy (101)
GLP-1 (347)
Government (1301)
Grass and pollen (2)
Guidances (16)
Healthcare (3582)
Huntington's disease (4)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (12)
Infectious disease (795)
Inflammatory bowel disease (54)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (47)
Interviews (59)
IPO (5887)
IRA (29)
Job creations (2051)
Job search strategy (373)
Kidney cancer (6)
Labor market (11)
Layoffs (180)
Leadership (3)
Legal (3441)
Liver cancer (19)
Lung cancer (80)
Lymphoma (53)
Machine learning (1)
Management (16)
Manufacturing (152)
MASH (32)
Medical device (1281)
Medtech (1283)
Mergers & acquisitions (9692)
Metabolic disorders (257)
Multiple sclerosis (20)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (6)
Neuroscience (578)
NextGen: Class of 2025 (1594)
Non-profit (598)
Northern California (701)
Now hiring (7)
Obesity (147)
Opinion (119)
Ovarian cancer (21)
Pain (50)
Pancreatic cancer (13)
Parkinson's disease (46)
Partnered (8)
Patents (114)
Patient recruitment (28)
Peanut (10)
People (28982)
Pharmaceutical (64)
Pharmacy benefit managers (11)
Phase I (8058)
Phase II (13109)
Phase III (11748)
Pipeline (437)
Policy (68)
Postmarket research (1403)
Preclinical (3218)
Press Release (25)
Prostate cancer (46)
Psychedelics (8)
Radiopharmaceuticals (120)
Rare diseases (166)
Real estate (2641)
Recruiting (17)
Regulatory (10121)
Reports (14)
Research institute (568)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (37)
Series A (36)
Series B (12)
Service/supplier (3)
Sickle cell disease (32)
Southern California (719)
Special edition (6)
Spinal muscular atrophy (77)
Sponsored (6)
Startups (1633)
State (2)
Stomach cancer (3)
Supply chain (31)
Tariffs (21)
The Weekly (30)
United States (7136)
Vaccines (152)
Venture capitalists (14)
Weight loss (99)
Women's health (8)
Worklife (3)
Date
Today (44)
Last 7 days (184)
Last 30 days (894)
Last 365 days (11862)
2025 (3429)
2024 (12530)
2023 (14274)
2022 (19592)
2021 (20115)
2020 (19053)
2019 (14963)
2018 (11788)
2017 (13907)
2016 (13156)
2015 (15501)
2014 (12423)
2013 (10601)
2012 (11403)
2011 (11928)
2010 (10896)
Location
Africa (313)
Alabama (13)
Alaska (1)
Arizona (55)
Arkansas (3)
Asia (20113)
Australia (2613)
California (1704)
Canada (900)
China (235)
Colorado (65)
Connecticut (67)
Delaware (54)
Europe (39494)
Florida (321)
Georgia (38)
Idaho (9)
Illinois (195)
India (16)
Indiana (134)
Iowa (1)
Japan (90)
Kansas (57)
Kentucky (12)
Louisiana (1)
Maine (2)
Maryland (252)
Massachusetts (1469)
Michigan (30)
Minnesota (93)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (8)
New Hampshire (6)
New Jersey (761)
New Mexico (7)
New York (502)
North Carolina (386)
North Dakota (2)
Northern California (701)
Ohio (49)
Oklahoma (4)
Oregon (16)
Pennsylvania (435)
Puerto Rico (8)
Rhode Island (9)
South America (502)
South Carolina (2)
Southern California (719)
Tennessee (34)
Texas (227)
Utah (33)
Virginia (72)
Washington D.C. (31)
Washington State (117)
Wisconsin (15)
266,034 Results for "constellation pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
News
CipherHealth Earns Third Consecutive Inclusion in Constellation ShortList for Healthcare Clinical Communication
August 21, 2024
·
3 min read
Genetown
Cellular Origins Launches Constellation, Its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and space-efficient manufacture of cell and gene therapies, has announced the launch of Constellation™, its closed, configurable, robotic platform at the International Society for Cell and Gene Therapy Annual Meeting 2023.
May 31, 2023
·
2 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Press Releases
MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors
April 7, 2025
·
6 min read
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
Genetown
Constellation Pharmaceuticals Presents at J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that Jigar Raythatha, CEO, will present a company overview at the J.P. Morgan Healthcare Conference at 10:50 AM EST on Thursday, January 14, 2021. A live audio webcast of the presentation and archive for replay will be available on the Investor Relations section of Constellation’s website at http://ir.constellationpharma.com/events-and-presentations/events . The audio webca
January 6, 2021
·
1 min read
Business
MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma
MorphoSys AG (FSE:MOR) announces today that it has entered into a definitive agreement with Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) whereby MorphoSys will acquire Constellation for $34.00 per share in cash, which represents a total equity value of $1.7 billion.
June 2, 2021
·
13 min read
MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals
MorphoSys AG (FSE:MOR)(NASDAQ:MOR) (“MorphoSys”) today announced that it is commencing a cash tender offer to purchase all outstanding shares of Constellation Pharmaceuticals, Inc., (CNST) (“Constellation”) for $34.00 per share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes.
June 16, 2021
·
7 min read
Press Releases
KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
April 8, 2025
·
4 min read
Genetown
Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference - May 31, 2021
Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, announced that the Company will participate in an upcoming virtual investor conference.
May 31, 2021
·
1 min read
1 of 26,604
Next
